Adenovirus-Transduced Lung as a Portal for Delivering α-Galactosidase A into Systemic Circulation for Fabry Disease
Open Access
- 30 June 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (6), 745-754
- https://doi.org/10.1006/mthe.2002.0605
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Preselective gene therapy for Fabry diseaseProceedings of the National Academy of Sciences, 2001
- Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry miceProceedings of the National Academy of Sciences, 2001
- Enzymatic corrections for cells derived from Fabry disease patients by a recombinant adenovirus vectorJournal of Human Genetics, 2000
- Correction of Enzymatic and Lysosomal Storage Defects in Fabry Mice by Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1999
- Neonatal Intramuscular Injection with Recombinant Adeno-Associated Virus Results in Prolonged beta-Glucuronidase Expression in Situ and Correction of Liver Pathology in Mucopolysaccharidosis Type VII MiceHuman Gene Therapy, 1999
- Gene transfer and expression of humanα-galactosidase from mouse muscle in vitro andin vivoGene Therapy, 1997
- α-Galactosidase A deficient mice: A model of Fabry diseaseProceedings of the National Academy of Sciences, 1997
- Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector.Proceedings of the National Academy of Sciences, 1996
- LYSOSOMAL STORAGE DISEASESAnnual Review of Biochemistry, 1991
- An Atypical Variant of Fabry's Disease with Manifestations Confined to the MyocardiumNew England Journal of Medicine, 1991